AYURCANN HOLDINGS CORP. PROVIDES CORPORATE OVERVIEW

AYURCANN HOLDINGS CORP. PROVIDES CORPORATE OVERVIEW

Toronto, Ontario, Canada -- October 6, 2021 -- InvestorsHub NewsWire -- Ayurcann Holdings Corp. (CSE: AYUR) (FSE: 3ZQ0) (the "Company" or "Ayurcann"), would like to provide current and prospective investors with a corporate overview on the Company and its operations.

Introduction to Ayurcann Holdings Corp.

Ayurcann is a cannabis extraction and white label product manufacturing company focused on the Canadian market and strategic partnerships with International Brands. Ayurcann offers turn-key extraction, product formulation and manufacturing solutions in the Cannabis Industry. The Company operates out of Pickering, Ontario, within a close proximity to over 200 licensed cannabis producers ("LPs"), with annual capacity to process 200,000 kg of biomass and over 1m filling work.

Company Highlights

Seasoned management team led by 2 founders with strong entrepreneurial backgrounds who have run multiple profitable businesses in a variety of industries to successful exits.

Licences
Granted an R&D license in August 2019 to start formulation and IP development concentrating on high potency recreational and medicinal THC and CBD products.
Granted a Standard Processor License in January 2020 and offering scalable white label production and toll processing solutions to Canadian LPs and international cannabis brands.
Granted an Amendment to the "Standard Processing Licence" to allow for sales in January 2021.

Production

Fully built-out extraction and manufacturing facility with a focus on high margin extract products in Cannabis 2.0 and 3.0.
Current yearly capacity for co-packaging of over 1 million vape and tincture filling.
Expansion into Phase II offering the ability to broaden white label manufacturing and fulfillment capabilities. Expended extraction and processing capacity of up to 300,000 kg/year

Financial

Debt FREE with substantial equity ownership by management and insiders.
Over $2,500,000 in revenue the last quarter and over $1,000,000 in positive adjusted EBITDA

Key Strategy

Ayurcann believes that it is targeting an underserved market, which is currently dominated by a handful of larger unprofitable Ayurcann believes that this leaves a great opportunity for a flexible and profitable company to gain market share and service small and mid-sized companies that do not have in-house extraction, manufacturing, or product formulation capabilities. Ayurcann has secured orders with both publicly listed Canadian and international companies.

To learn more on the Company, please visit www.Ayurcann.com, and the Company's SEDAR profile at www.sedar.com.

For further information, please contact:

Igal Sudman, Chairman, Chief Executive Officer and Corporate Secretary

Ayurcann Holdings Corp.

Tel: 905-492-3322

Email: info@ayurcann.com

Investor Relations:

Ryan Bilodeau

Tel: 416-910-1440

Email: ir@ayurcann.com

About Ayurcann Holdings Corp.:

Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company's expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company's facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company's business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.

Ayurcann (CSE:AYUR)
過去株価チャート
から 11 2024 まで 12 2024